CYTEK BIOSCIENCES INC (CTKB) Stock Income Statement
NASDAQ:CTKB - Nasdaq - US23285D1090 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 197.05M | 200.45M | 193.01M | 164.00M | 128.00M | |||
| Minority Interest Expense | N/A | 0.00 | 0.00 | 100.00K | 0.00 | |||
| Cost Of Goods | 88.80M | 89.35M | 83.59M | 63.10M | 48.80M | |||
| Gross Profit | 108.25M | 111.11M | 109.43M | 101.00M | 79.10M | |||
| Operating Expenses | 133.01M | 131.63M | 137.27M | 102.70M | 69.80M | |||
| Research and Development | 39.33M | 39.40M | 44.15M | 34.90M | 24.40M | |||
| Selling, General, and Administrative Expenses | 93.68M | 92.23M | 93.12M | 67.90M | 45.30M | |||
| Operating Income | -24.76M | -20.52M | -27.84M | -1.80M | 9.40M | |||
| Interest Income/Expense | 9.66M | -29.64M | 4.30M | 2.00M | -1.70M | |||
| Other Income/Expense | 7.13M | 44.46M | 7.83M | 1.10M | -1.50M | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | -200.00K | |||
| Income Before Taxes | -7.97M | -5.70M | -15.71M | 1.30M | 5.90M | |||
| Income Tax | 3.28M | 320.00K | -3.56M | -1.20M | 2.90M | |||
| Net Income | -11.25M | -6.02M | -12.15M | 2.60M | 0.00 | |||
| EBITDA | -13.09M | -10.03M | -18.61M | 690.00K | 10.64M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.09 | -0.05 | -0.09 | 0.02 | 0.00 | |||
| Non GAAP EPS | -0.09 | -0.05 | 0.05 | 0.14 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 54.94% | 55.43% | 56.69% | 61.59% | 61.80% | |||
| Profit Margin | -5.71% | -3.00% | -6.29% | 1.59% | N/A | |||
| Operating Profit Margin | -12.57% | -10.24% | -14.43% | -1.10% | 7.34% | |||
All data in USD